Tempest Therapeutics, Inc.
TPST
$10.03
$0.6757.22%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.10M | -44.80M | -41.84M | -35.52M | -31.75M |
| Total Depreciation and Amortization | 281.00K | 369.00K | 389.00K | 425.00K | 416.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.38M | 6.70M | 6.81M | 6.75M | 6.14M |
| Change in Net Operating Assets | -355.00K | 3.85M | 1.61M | -705.00K | -163.00K |
| Cash from Operations | -36.80M | -33.88M | -33.03M | -29.05M | -25.36M |
| Capital Expenditure | -18.00K | -267.00K | -435.00K | -439.00K | -424.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -18.00K | -267.00K | -435.00K | -439.00K | -424.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10.82M | -6.60M | -4.40M | -2.20M | -- |
| Issuance of Common Stock | 28.94M | 29.93M | 28.90M | 43.10M | 39.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.86M | -- | -- | -- | -- |
| Cash from Financing | 19.97M | 23.33M | 24.50M | 40.90M | 39.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.84M | -10.82M | -8.96M | 11.41M | 13.60M |